<DOC>
	<DOCNO>NCT00495053</DOCNO>
	<brief_summary>The purpose study evaluate safety new product use human gene transfer ( call hMaxi-K ) give patient overactive bladder . Human gene transfer new type therapy process place genetic material ( DNA RNA ) person . The primary objective study evaluate safety parameter occur subsequent administration single intravesical instillation study drug . Three different dose group hMaxi-K test study consist 5000 , 10,000 15,000 microgram . hMaxi-K give single administration bladder catheter . Each woman 's participation study last 24 week ( follow additional 18 month follow-up period ) .</brief_summary>
	<brief_title>Safety Study hMaxi-K Gene Transfer Treat Overactive Bladder Syndrome Detrusor Overactivity</brief_title>
	<detailed_description>The safety parameter monitor include : adverse event , clinical laboratory test , electrocardiogram , physical examination . The secondary objective evaluate efficacy single intravesical instillation hMaxi-K compare control group . Efficacy parameter evaluate : mean number micturition per 24 hour , mean number urge incontinence episode per 24 hour , mean number urgency episodes per 24 hour , overall maximum bladder capacity , number uninhibited contraction cystometry procedure , participant rating urgency score , participant rating perceive bladder condition severity , participant assessment response treatment , participant rating Quality Life ( Kings Health Questionnaire ) , SF-12 Health Survey , International consultation incontinence questionnaire , weight measurement accidental bladder leak .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>Healthy woman 18 year age old nonchildbearing potential clinical symptom overactive bladder 6 month longer include least one following : 1. frequent urination ( , go bathroom 8 time per day ) 2. symptom urinary urgency , experience sudden need pas urine difficult hold back ; complaint wake night two ore time urinate 3. urge urinary incontinence complaint leakage urine stop accompany immediately preceded urgency 5 time per week . Nonresponse poor tolerance previous treatment symptom overactive bladder wish continue treatment . A woman positive serum ( HCG ) pregnancy test lactate History three culture document recurrent urinary tract infection per year Current history previous diagnosis painful bladder syndrome ( interstitial cystitis ) pain region pelvis , perineum , low abdomen relieve void A life expectancy le 12 month Current history Grade 2 great cystocele An indwelling urethral catheter need clean intermittent self catheterization Recent heart attack Uncontrolled diabetes Latex allergy Stress urinary incontinence determine observation participant cough stand full bladder and/or response 2 3 follow Stress Urinary Incontinence question : Do experience leakage laughing , cough , lift heavy object types discreet , moderately intense activity ? 0=NONE : No leakage 1=MILD : Minimal leakage rare occasion type activity ; easily tolerate ; use pad 2=MODERATE : Enough leakage require occasional use pad may interfere usual activity &amp; task 3=SEVERE : Extreme leakage discomfort stop activity &amp; /tasks require use pad occasion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>overactive bladder , urinary urgency</keyword>
</DOC>